LBSCX
Price
$31.60
Change
-$0.76 (-2.35%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

LBSCX vs RMFCX

Header iconLBSCX vs RMFCX Comparison
Open Charts LBSCX vs RMFCXBanner chart's image
Columbia Dividend Income C
Price$31.60
Change-$0.76 (-2.35%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
LBSCX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LBSCX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LBSCX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. LBSCX (42.2B). RMFCX pays higher dividends than LBSCX: RMFCX (1.69) vs LBSCX (0.87). LBSCX was incepted earlier than RMFCX: LBSCX (22 years) vs RMFCX (23 years). RMFCX is a more actively managed with annual turnover of: 25.00 vs. LBSCX (17.00). RMFCX has a lower initial minimum investment than LBSCX: RMFCX (250) vs LBSCX (2000). RMFCX (12.63) and LBSCX (12.02) have marching annual gain over last year. LBSCX return over 5 years is better than : 42.69 vs. RMFCX (40.39).
LBSCXRMFCXLBSCX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years23 years-
Gain YTD11.36711.423100%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets42.2B98.7B43%
Annual Yield % from dividends0.871.6952%
Returns for 1 year12.0212.6395%
Returns for 3 years12.4614.1688%
Returns for 5 years42.6940.39106%
Returns for 10 years84.2361.84136%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc